Table 1.
Study methods for included randomised controlled trials
Study name | Study duration | Country | Blinding | Intervention | Comparator | Daily dose of nicergoline (mg) |
---|---|---|---|---|---|---|
Arrigo et al7 | 14 weeks | Italy | Double-blind | Nicergoline | Placebo | 60 |
Battaglia et al8 | 6 months | Italy | Double-blind | Nicergoline | Placebo | 60 |
Battaglia et al9 | 6 months | Italy | Double-blind | Nicergoline | Ergot mesylates | 60 |
Battaglia et al10 | 12 months | Italy | Double-blind | Nicergoline | Placebo | 60 |
Bes et al11 | 24 months | France | Double-blind | Nicergoline | Placebo | 60 |
Bossi12 | – | Italy | Double-blind | Nicergoline | Buflomedil | 8 |
Brola13 | 1 month | Poland | Single-blind | Nicergoline | Pentoxifylline | 30 |
Cascone et al14 | 1 month | Italy | Double-blind | Nicergoline | Placebo | 15 |
Colombeau and Ballanger15 | 15 days | France | Double-blind | Nicergoline | Placebo | 40 |
Crook16 | 6 months | USA | Double-blind | Nicergoline | Placebo | 60 |
Dubreuil17 | 1 month | France | Double-blind | Nicergoline | GBE | NR |
Felisati et al18 | 3 months | Italy | Double-blind | Nicergoline | Placebo | 60 |
Forette et al19 | 3 weeks | France | Double-blind | Nicergoline | Placebo | 30 |
Gessner et al20 | 12 weeks | Germany | Double-blind | Nicergoline | GBE | 15 |
Herrmann21 | 6 months | Germany | Double-blind | Nicergoline | Placebo | 60 |
Kugler and Meurer-Krull22 | 6 months | Germany | Double-blind | Nicergoline | Dihydroergotamine | 30 |
Lu23 | 12 weeks | China | Double-blind | Nicergoline | Aniracetam | 60 |
Marolda et al24 | 20 days | Italy | Double-blind | Nicergoline | Eburnamonine | 15–20 |
Materna25 | 12 weeks | Germany | Double-blind | Nicergoline | Flunarizine | 10–30 |
Nakashima et al26 | 6 months | Japan | Double-blind | Nicergoline | Imidapril | 15 |
Nappi et al27 | 12 months | Italy | Double-blind | Nicergoline | Placebo | 60 |
Nishiyama et al28 | 4 weeks | Japan | Open-label | Nicergoline | Placebo | 45 |
Pilkowska et al29 | 3 months | Poland | Double-blind | Nicergoline | Placebo | 60 |
Pogliani 197930 | 3 months | Germany | Double-blind | Nicergoline | Placebo | 15 |
Ronchi et al31 | 6 days | Italy | Double-blind | Nicergoline | Placebo | |
Saletu et al32 | 8 weeks | Austria | Double-blind | Nicergoline | Placebo | 30–60 |
Setyopranoto et al33 | – | Indonesia | Double-blind | Nicergoline | Placebo | 60 |
Winblad et al34 | 6 months | Europe | Double-blind | Nicergoline | Placebo | 60 |
Zucconi and Terzi Bolaffio35 | 1 month | Italy | Double-blind | Nicergoline | Dihydroergotoxine | 2 intramuscular |
GBE, ginkgo biloba extract; NR, not reported.